by With rising incidence of skin cancers and skin disorders such as benign lesions that require surgical removal, the demand for accurate and effective skin excision procedures is increasing. Skin excision involves surgically removing abnormal or damaged skin using techniques like shaving, tangential, elliptical or Mohs micrographic surgery. Advances in minimally invasive skin grafting methods allow surgeons to excise lesions with reduced wound size, post-operative pain and scarring compared to traditional methods.
The Global Skin Excision Market is estimated to be valued at US$ 29.9 billion in 2024 and is expected to exhibit a CAGR of 9.0% over the forecast period from 2024 to 2031.
Key Takeaways
Key players operating in The Global Skin Excision Market are Ethicon Inc., Richard Wolf GMBH, Becton, Dickinson and Company, Integra LifeSciences, Exsurco Medical, Limbs & Things LTD, KARL STORZ GmbH & Co. KG, Aesculap, Inc., Medtronic, Zimmer Biomet, B. Braun SE, Conmed Corporation, Symmetry Surgical Inc., and Surtex Instruments Limited.
The companies are focusing on improving device ergonomics, visualization capabilities, and minimizing surgical trauma through new procedural techniques and instrumentation.
The rising incidence of skin cancers and need for tissue conservation is presenting lucrative opportunities for advanced tissue-sparing skin grafting methods. Technologies like MMS, C02 lasers and PDT are improving aesthetic outcomes after tumor or lesion removal.
Advancements in imaging technologies, computer-aided surgery platforms and minimally invasive instruments allow for improved lesion visualization, definition of margins and reduced surgical footprints compared to open techniques. This is increasing the uptake of skin excision procedures.
Market Drivers
One of the key drivers of the skin excision market is the rising global prevalence of non-melanoma skin cancers, particularly basal cell carcinoma and squamous cell carcinoma. Changing environmental conditions, greater exposure to UV radiation and growing elderly population are contributing to higher skin cancer incidence rates worldwide. Moreover, technological advancements enabling minimized wound sizes and scarring with skin grafting are encouraging more patients to undergo surgical treatment of benign skin lesions, thus propelling market revenues.
Challenges in the Global Skin Excision Market
Some of the key challenges faced by the global skin excision market are: maintaining quality standards, high capital investment requirements for equipment and facilities, regulations and compliance, and shortage of trained medical professionals. Strict regulations around safety, efficacy and quality ensure patients receive appropriate treatment, but they also increase compliance costs for manufacturers and service providers. Significant investments are needed to set up specialized surgical centers, purchase expensive equipment like dermatology devices and lasers, and train staff. This poses hurdles for new market entrants. Additionally, the market suffers from a lack of dermatologists and surgeons skilled in advanced skin excision procedures. This challenge is more pronounced in developing regions.
SWOT Analysis
Strength: Non-invasive treatments help avoid scarring and reduce recovery time. Growing awareness about skin health and aesthetics drives demand.
Weakness: High costs of laser treatments limit access. Requirement of specialized infrastructure and trained professionals.
Opportunity: Rising skin cancer incidence rates worldwide create need. Untapped growth potential in emerging Asian and Latin American countries.
Threats: Threat of substitutes like chemical peels and injectable treatments. Stringent regulations around new product approvals.
Geographical Regions
North America currently holds the largest share of the global skin excision market, valued at over US$ 12 billion in 2024. This is attributed to the region’s highly developed healthcare infrastructure and rising skin cancer prevalence in countries like the US and Canada. However, the Asia Pacific region is projected to witness the fastest CAGR during the forecast period, driven by growing medical tourism, rising discretionary incomes, and increasing government focus on public health in China, India and other Asian nations.
Another fast growing regional market is Latin America. Countries like Brazil, Mexico and Argentina are seeing higher skin excision procedures due to growing obesity rates, excessive sun exposure and a rise in skin cancer diagnosis. Improving access to healthcare and medical insurance coverage will further stimulate demand across emerging Latin American countries.
